Table 5 Baseline demographics and angiographic characteristics of diabetes population with successful and failed PCI after propensity score matching
|  | Success (n = 188) | Failed (n = 47) | P value |
|---|---|---|---|
Age, years | 71 ± 12 | 71 ± 13 | 0.96 |
Gender (Male) | 158 (84) | 41 (87) | 0.66 |
Hypertension | 160 (85) | 42 (89) | 0.64 |
Hyperlipidemia | 80 (43) | 24 (51) | 0.33 |
Prior stroke | 19 (10) | 6 (13) | 0.60 |
PAD | 16 (9) | 7 (15) | 0.27 |
Smoking | 61 (32) | 17 (36) | 0.73 |
Prior MI | 56 (30) | 16 (34) | 0.60 |
Prior CAD | 111 (59) | 24 (51) | 0.33 |
Prior CABG | 18 (10) | 9 (19) | 0.08 |
LVEF, % | 47 ± 12 | 47 ± 12 | 0.92 |
eGFR, MDRDc (ml/min) | 69 ± 29 | 68 ± 30 | 0.76 |
LDL (mg/dl) | 98 ± 34 | 93 ± 29 | 0.51 |
HbA1C, % | 7.7 ± 1.6 | 8 ± 1.5 | 0.49 |
Location of CTO | |||
 LAD | 14 (26) | 5 (39) | 0.50 |
 LCx | 28 (44) | 1 (11) | 0.08 |
 RCA | 23 (37) | 10 (56) | 0.18 |
Multivessel CTO | 29 (15) | 15 (32) | 0.05 |
J CTO score | 2.4 ± 0.5 | 2.5 ± 0.6 | 0.60 |
Syntax score | 18 ± 5 | 19 ± 5 | 0.78 |
MVD | 163 (87) | 45 (96) | 0.05 |
Lesion length (mm) | 37 ± 18 | 31 ± 8 | 0.12 |
Lesion width (mm) | 3.0 ± 2.0 | 3.0 ± 0.6 | 0.92 |
Retrograde approach | 14 (8) | 2 (5) | 0.89 |